Synairgen
Trial of potential new COVID-19 treatment begins in UK
January 13, 2021Research and Development COVID-19, Synairgen, Vaccine
A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
July 20, 2020Research and Development, Sales and Marketing COVID-19, Synairgen
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
AstraZeneca forced to abandon Phase II trial
October 12, 2016Research and Development AstraZeneca, Synairgen, asthma, cold, common cold
Synairgen, a respiratory drug discovery and development company, has developed a drug, AZD9412, alongside AstraZeneca to treat and prevent severe …
AstraZeneca signs $240m asthma deal with UK biotech
June 12, 2014Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
Latest content
Five Facts about NHS and primary care
September 5, 2026
AI in pharma: From lab development to patient impact
September 5, 2026
